Reckitt Benckiser (RB/ LN, BUY, T/P 6900p) started 2016 strongly with 5% like for like growth in Q1 compared with a 4.9% consensus. While the rounded number is technically the same as Unilever’s (ULVR LN, HOLD, T/P 3050p) 4.7% Q1 announced last week, we argue Reckitt’s superior geographic growth mix gives the company the edge. Moreover, given its unusual strength in and the opportunity for consumer health, we reiterate our BUY recommendation for the shares.
18 Apr 2016
Brisk Start to 2016 with 5% L4L sales growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Brisk Start to 2016 with 5% L4L sales growth
Reckitt Benckiser Group plc (RKT:LON) | 4,521 3345.5 1.7% | Mkt Cap: 32,030m
- Published:
18 Apr 2016 -
Author:
Chris Wickham -
Pages:
3
Reckitt Benckiser (RB/ LN, BUY, T/P 6900p) started 2016 strongly with 5% like for like growth in Q1 compared with a 4.9% consensus. While the rounded number is technically the same as Unilever’s (ULVR LN, HOLD, T/P 3050p) 4.7% Q1 announced last week, we argue Reckitt’s superior geographic growth mix gives the company the edge. Moreover, given its unusual strength in and the opportunity for consumer health, we reiterate our BUY recommendation for the shares.